Literature DB >> 18458263

Developing the evidence for evidence-based practice.

A John Rush1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18458263      PMCID： PMC2335183          DOI： 10.1503/cmaj.080202

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

Review 1.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors.

Authors:  H C Kraemer; E Stice; A Kazdin; D Offord; D Kupfer
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

Review 2.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

3.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

4.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

5.  The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

Authors:  I W Miller; G I Keitner; A F Schatzberg; D N Klein; M E Thase; A J Rush; J C Markowitz; D S Schlager; S G Kornstein; S M Davis; W M Harrison; M B Keller
Journal:  J Clin Psychiatry       Date:  1998-11       Impact factor: 4.384

6.  Sertraline versus imipramine to prevent relapse in chronic depression.

Authors:  L M Koran; A J Gelenberg; S G Kornstein; R H Howland; R A Friedman; C DeBattista; D Klein; J H Kocsis; A F Schatzberg; M E Thase; A J Rush; R M Hirschfeld; L M LaVange; M B Keller
Journal:  J Affect Disord       Date:  2001-06       Impact factor: 4.839

Review 7.  Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials.

Authors:  Dorian Deshauer; David Moher; Dean Fergusson; Ester Moher; Margaret Sampson; Jeremy Grimshaw
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

8.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

9.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

10.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Authors:  Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242
View more
  2 in total

1.  Bringing a research base to psychiatry.

Authors:  Miriam Shuchman; Paul C Hébert; Rajendra Kale; Barbara Sibbald; Ken Flegel; Noni MacDonald
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

2.  Circulating microRNA associated with future relapse status in major depressive disorder.

Authors:  Qingqin S Li; David Galbraith; Randall L Morrison; Madhukar H Trivedi; Wayne C Drevets
Journal:  Front Psychiatry       Date:  2022-08-17       Impact factor: 5.435
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.